Dr. Konstantin H. Dragnev
Claim this profileDartmouth Hitchcock Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
42 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage I
Stage IV
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Konstantin H. Dragnev is currently running
MT-6402
for Solid Cancers
This will be a Phase 1 Open-label, dose escalation and expansion study of MT-6402 (an Engineered Toxin Body (ETB)) in subjects with advanced solid cancer that expresses PD-L1
Recruiting1 award Phase 110 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Konstantin H. Dragnev
Clinical Trial Related5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Konstantin H. Dragnev has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Telaglenastat
- Trilaciclib
- Lurbinectedin
Breakdown of trials Konstantin H. Dragnev has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Konstantin H. Dragnev specialize in?
Konstantin H. Dragnev focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Konstantin H. Dragnev currently recruiting for clinical trials?
Yes, Konstantin H. Dragnev is currently recruiting for 8 clinical trials in Lebanon New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Konstantin H. Dragnev has studied deeply?
Yes, Konstantin H. Dragnev has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with Konstantin H. Dragnev?
Apply for one of the trials that Konstantin H. Dragnev is conducting.
What is the office address of Konstantin H. Dragnev?
The office of Konstantin H. Dragnev is located at: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.